Eton Pharmaceuticals (ETON) Capital Expenditures (2018 - 2025)

Eton Pharmaceuticals has disclosed Capital Expenditures across 7 years of filings, most recently posting $49000.0 for Q4 2025.

• In Q4 2025, Capital Expenditures rose 308.33% year-over-year to $49000.0; the TTM figure through Dec 2025 stood at $333000.0 (up 1180.77% YoY), while the FY2025 annual figure was $333000.0, up 1180.77% from the prior year.
• Capital Expenditures came in at $49000.0 for Q4 2025 at Eton Pharmaceuticals, down from $284000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $284000.0 in Q3 2025 to a low of $2000.0 in Q3 2021.
• Average Capital Expenditures over 4 years is $44777.8, with a median of $12000.0 recorded in 2022.
• Year-over-year, Capital Expenditures slumped 90.91% in 2021 and surged 308.33% in 2025.
• Over 4 years, Capital Expenditures stood at $4000.0 in 2021, then soared by 200.0% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2024, then jumped by 308.33% to $49000.0 in 2025.
• Per Business Quant data, the three most recent Capital Expenditures figures were $49000.0 in Q4 2025, $284000.0 in Q3 2025, and $12000.0 in Q4 2024.